| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
|---|---|---|---|---|---|---|---|---|
| Q2 2024 | 46 | $4.72B | +$916M | -$1.15B | -$231M | THC, CVS, CI, GPN, CTVA | 13F-HR | 8/14/2024, 04:09 PM |
| Q1 2024 | 43 | $5.13B | +$998M | -$786M | +$213M | THC, CI, CTVA, UHS, GPN | 13F-HR | 5/15/2024, 04:23 PM |
| Q4 2023 | 41 | $4.29B | +$805M | -$699M | +$105M | CI, THC, DXC, UHS, GPN | 13F-HR | 2/14/2024, 04:26 PM |
| Q3 2023 | 47 | $3.68B | +$779M | -$496M | +$284M | THC, CI, UHS, GPN, DXC | 13F-HR | 11/14/2023, 04:30 PM |
| Q2 2023 | 46 | $3.72B | +$343M | -$1.14B | -$793M | CI, THC, DXC, UHS, GPN | 13F-HR | 8/14/2023, 04:13 PM |
| Q1 2023 | 53 | $4.07B | +$549M | -$773M | -$224M | CI, THC, FI, GPN, DXC | 13F-HR | 5/15/2023, 04:18 PM |
| Q4 2022 | 51 | $4.17B | +$637M | -$752M | -$116M | CI, THC, DXC, FI, MCK | 13F-HR | 2/14/2023, 04:21 PM |
| Q3 2022 | 53 | $3.94B | +$667M | -$556M | +$111M | CI, THC, FI, DXC, GPN | 13F-HR | 11/14/2022, 04:12 PM |
| Q2 2022 | 53 | $3.93B | +$649M | -$806M | -$158M | CI, THC, GPN, DXC, MCK | 13F-HR | 8/11/2022, 04:15 PM |
| Q1 2022 | 58 | $4.9B | +$1.08B | -$848M | +$228M | THC, CI, GPN, MCK, DXC | 13F-HR | 5/16/2022, 04:43 PM |
| Q4 2021 | 54 | $4.61B | +$379M | -$1.6B | -$1.22B | THC, MCK, BHC, GPN, CI | 13F-HR | 2/14/2022, 05:05 PM |
| Q3 2021 | 2 | $55.1M | $0 | $0 | QSI, EVLV | New Holdings | 2/18/2022, 05:16 PM | |
| Q3 2021 | 60 | $5.48B | +$738M | -$1B | -$264M | THC, BHC, MCK, CI, COR | 13F-HR | 11/15/2021, 04:38 PM |
| Q2 2021 | 65 | $6.04B | +$1.23B | -$1.45B | -$218M | THC, BHC, CI, MCK, DXC | Restatement | 2/18/2022, 05:16 PM |
| Q1 2021 | 63 | $5.9B | +$1.79B | -$1.02B | +$771M | THC, BHC, CI, MCK, DXC | 13F-HR | 5/17/2021, 04:06 PM |
| Q4 2020 | 54 | $4.28B | +$638M | -$498M | +$141M | THC, BHC, TAK, DXC, CI | 13F-HR | 2/16/2021, 04:16 PM |
| Q3 2020 | 45 | $3.19B | +$122M | -$858M | -$736M | THC, TAK, BHC, CI, HCA | 13F-HR | 11/16/2020, 04:09 PM |
| Q2 2020 | 43 | $3.62B | +$508M | -$1.37B | -$865M | THC, TAK, BHC, CI, HCA | 13F-HR | 8/14/2020, 04:06 PM |
| Q1 2020 | 44 | $3.68B | +$239M | -$4.8B | -$4.56B | TAK, THC, CI, BHC, HCA | 13F-HR | 5/15/2020, 04:07 PM |
| Q4 2019 | 50 | $11.4B | +$2.01B | -$1.9B | +$109M | HCA, CI, THC, PARA, TAK | 13F-HR | 2/14/2020, 04:18 PM |
| Q3 2019 | 49 | $9.51B | +$1.05B | -$2.04B | -$991M | CI, HCA, MCK, IQV, TAK | 13F-HR | 11/14/2019, 04:07 PM |
| Q2 2019 | 46 | $11B | +$1.08B | -$1.19B | -$104M | CI, HCA, IQV, FMC, MCK | 13F-HR | 8/14/2019, 04:07 PM |
| Q1 2019 | 45 | $11.2B | +$2.93B | -$3.35B | -$421M | DXC, FMC, CI, MCK, IQV | 13F-HR | 5/15/2019, 04:06 PM |
| Q4 2018 | 48 | $10.3B | +$1.82B | -$4.74B | -$2.92B | SHPG, FMC, IQV, HCA, CVS | 13F-HR | 2/14/2019, 04:12 PM |
| Q3 2018 | 57 | $15.7B | +$1.93B | -$2.14B | -$204M | ESRX, FMC, AET, IQV, MCK | 13F-HR | 11/14/2018, 04:09 PM |
| Q2 2018 | 50 | $14.7B | +$936M | -$3.83B | -$2.89B | SHPG, DWDP, FMC, MCK, THC | 13F-HR | 8/14/2018, 04:08 PM |
| Q1 2018 | 53 | $17.1B | +$1.97B | -$2.65B | -$680M | HCA, SHPG, DWDP, FMC, IQV | 13F-HR | 5/15/2018, 04:07 PM |
| Q4 2017 | 58 | $18.5B | +$4.5B | -$4.06B | +$431M | HCA, DWDP, FMC, SHPG, IQV | 13F-HR | 2/14/2018, 04:26 PM |
| Q3 2017 | 56 | $17.2B | +$3.5B | -$2.27B | +$1.23B | HCA, DWDP, FMC, SHPG, Q | 13F-HR | 11/14/2017, 04:18 PM |
| Q2 2017 | 52 | $15.4B | +$2.67B | -$3.05B | -$378M | HCA, FMC, DOW, Q, ELV | 13F-HR | 8/14/2017, 04:26 PM |
| Q1 2017 | 51 | $15.1B | +$1.36B | -$2.55B | -$1.19B | HCA, HUM, ELV, DOW, FMC | 13F-HR | 5/15/2017, 04:23 PM |
| Q4 2016 | 48 | $14.8B | +$2.78B | -$2.33B | +$449M | HCA, HUM, ELV, CI, AET | 13F-HR | 2/14/2017, 04:25 PM |
| Q3 2016 | 50 | $14B | +$2.14B | -$2.74B | -$608M | HUM, HCA, CI, CBS, ELV | 13F-HR | 11/14/2016, 04:20 PM |
| Q2 2016 | 47 | $14.1B | +$1.7B | -$1.55B | +$147M | HUM, HCA, MON, CI, ABBV | 13F-HR | 8/15/2016, 04:10 PM |
| Q1 2016 | 45 | $13.7B | +$478M | -$4.24B | -$3.76B | HUM, HCA, MON, CI, ABBV | 13F-HR | 5/16/2016, 04:11 PM |
| Q4 2015 | 55 | $17.8B | +$2.84B | -$5.44B | -$2.6B | HUM, MON, CI, HCA, TMO | 13F-HR | 2/16/2016, 04:52 PM |
| Q3 2015 | 78 | $20.2B | +$2.25B | -$3.66B | -$1.41B | HUM, MON, TMO, ABBV, FLEX | 13F-HR | 11/16/2015, 04:11 PM |
| Q2 2015 | 81 | $25.3B | +$6.56B | -$3.56B | +$3B | HUM, TMO, ABBV, MON, THC | 13F-HR | 8/14/2015, 04:11 PM |
| Q1 2015 | 80 | $21.9B | +$4.2B | -$2.91B | +$1.29B | MON, FLEX, TMO, HUM, ELV | 13F-HR | 5/15/2015, 04:18 PM |
| Q4 2014 | 74 | $20B | +$3.14B | -$3.31B | -$169M | TMO, MON, FLEX, THC, CYH | 13F-HR | 2/17/2015, 04:13 PM |
| Q3 2014 | 74 | $19.1B | +$4.14B | -$2.42B | +$1.72B | TMO, MON, THC, FLEX, HCA | 13F-HR | 11/14/2014, 04:09 PM |
| Q2 2014 | 68 | $17.2B | +$3.76B | -$2.51B | +$1.25B | TMO, MON, FLEX, HCA, THC | 13F-HR | 8/14/2014, 04:14 PM |
| Q1 2014 | 65 | $15.1B | +$4.18B | -$2.55B | +$1.63B | TMO, MON, HCA, CCI, THC | 13F-HR | 5/15/2014, 04:10 PM |
| Q4 2013 | 60 | $13.2B | $0 | $0 | TMO, HCA, THC, MON, CCI | 13F-HR | 2/14/2014, 04:20 PM |